SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-17-002182
Filing Date
2017-05-10
Accepted
2017-05-10 16:25:55
Documents
42
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT s106085_10q.htm 10-Q 319871
2 EXHIBIT 31.1 s106085_ex31-1.htm EX-31.1 7032
3 EXHIBIT 31.2 s106085_ex31-2.htm EX-31.2 6954
4 EXHIBIT 32.1 s106085_ex32-1.htm EX-32.1 4623
5 EXHIBIT 99.1 s106085_ex99-1.htm EX-99.1 16365
  Complete submission text file 0001615774-17-002182.txt   2297033

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE avxl-20170331.xml EX-101.INS 497835
7 XBRL SCHEMA FILE avxl-20170331.xsd EX-101.SCH 28410
8 XBRL CALCULATION FILE avxl-20170331_cal.xml EX-101.CAL 29487
9 XBRL DEFINITION FILE avxl-20170331_def.xml EX-101.DEF 90826
10 XBRL LABEL FILE avxl-20170331_lab.xml EX-101.LAB 218375
11 XBRL PRESENTATION FILE avxl-20170331_pre.xml EX-101.PRE 142936
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 17830660
SIC: 8731 Services-Commercial Physical & Biological Research